Jounce Therapeutics to Present Data from Ongoing ICONIC Trial of JTX-2011 at the 2018 American Society of Clinical Oncology Annual Meeting

World News: . []

CAMBRIDGE Mass May 16 2018 GLOBE NEWSWIRE --  Jounce Therapeutics Inc NASDAQJNCE a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers today announced that data fr om its ...

More news and information about Jounce Therapeutics, Inc.

Published By:

Globe Newswire: 22:01 GMT Wednesday 16th May 2018

Published: .

Search for other references to "jounce" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us